Josephine Forbes

Professorial Fellow

Mater Research Institute The University of Queensland

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Josephine Forbes is a Professorial Fellow at Mater Research Institute - The University of Queensland, Australia. Her research focuses on the implications of advanced glycation end products in relation to diabetes and kidney disease, along with exploring the efficacy of photobiomodulation in metabolic disorders. Recent publications include studies on mitochondrial dysfunction, inflammation in type 1 diabetes, and kidney injury mechanisms.

Articles (8)

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Kim Donaghue

University of Sydney

AUSTRALIA

View details

Jennifer Gunter

Queensland University of Technology

AUSTRALIA

View details

Tatjana Ewais

Griffith University

AUSTRALIA

View details

E-Liisa Laakso

University of Queensland

AUSTRALIA

View details

Linda A Gallo

Lecturer

University of the Sunshine Coast

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Josephine Forbes

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Efficacy and Safety of Photobiomodulation in MELAS: Protocol for a Series of N-of-1 Trials

Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development

Mitochondrial Dysfunction in Individuals with Diabetic Kidney Disease: A Systematic Review

Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?

T-Cell Expression and Release of Kidney Injury Molecule-1 in Response to Glucose Variations Initiates Kidney Injury in Early Diabetes

Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma

Going in Early: Hypoxia as a Target for Kidney Disease Prevention in Diabetes?

Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes

Collaborators (5)

Kim Donaghue

Jennifer Gunter

Tatjana Ewais

E-Liisa Laakso

Linda A Gallo

Make your next move.